Literature DB >> 2450462

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.

C Linington1, M Bradl, H Lassmann, C Brunner, K Vass.   

Abstract

In this study the authors have developed a model with which can be studied directly the influence of circulating anti-myelin antibody on the clinical and pathologic course of inflammatory T-cell-mediated experimental allergic encephalomyelitis (EAE) in the rat. EAE was induced by passive transfer of either myelin basic protein (MBP)-activated spleen cells derived from sensitized donors or long-term-cultured MBP-specific T-cell lines. At the onset of the disease, monoclonal antibodies against a myelin/oligodendrocyte glycoprotein (MOG) were injected intravenously. This antigen is exposed on the surface of central nervous system myelin and oligodendrocytes. Intravenous injection of the antibody in the course of T-cell-mediated transfer EAE augmented the severity and duration of clinical signs and resulted in the formation of large, confluent demyelinated plaques.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450462      PMCID: PMC1880661     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Mechanism of demyelination in the guinea pig. Separate sensitization with encephalitogenic myelin basic protein and nonencephalitogenic brain components.

Authors:  B F Driscoll; J Kira; M W Kies; E C Alvord
Journal:  Neurochem Pathol       Date:  1986-02

2.  Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig.

Authors:  T Tabira; M Endoh
Journal:  J Neurol Sci       Date:  1985-02       Impact factor: 3.181

3.  Demonstration of serum IgG antibodies against myelin during the course of relapsing experimental allergic encephalomyelitis in guinea pigs.

Authors:  T Olsson; K Kristensson; G Leijon; H Link
Journal:  J Neurol Sci       Date:  1982-06       Impact factor: 3.181

4.  Cerebroside antibody inhibits sulfatide synthesis and myelination and demyelinates in cord tissue cultures.

Authors:  J M Fry; S Weissbarth; G M Lehrer; M B Bornstein
Journal:  Science       Date:  1974-02-08       Impact factor: 47.728

5.  Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.

Authors:  J R Richert; B F Driscoll; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

6.  Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin.

Authors:  I Grundke-Iqbal; C S Raine; A B Johnson; C F Brosnan; M B Bornstein
Journal:  J Neurol Sci       Date:  1981-04       Impact factor: 3.181

7.  Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes.

Authors:  H Wekerle; M Schwab; C Linington; R Meyermann
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

8.  THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION.

Authors:  S H APPEL; M B BORNSTEIN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

9.  Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition.

Authors:  S S Zamvil; P A Nelson; D J Mitchell; R L Knobler; R B Fritz; L Steinman
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  173 in total

Review 1.  Therapeutic strategies in multiple sclerosis. I. Immunotherapy.

Authors:  R Hohlfeld
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

2.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

Authors:  T Chitnis; N Najafian; C Benou; A D Salama; M J Grusby; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

5.  Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 6.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

7.  Autoimmunity's next top models.

Authors:  Hartmut Wekerle; Alexander Flügel; Lars Fugger; Georg Schett; David Serreze
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

8.  Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Authors:  Yoh Matsumoto; Il-Kwon Park; Keiko Hiraki; Shin Ohtani; Kuniko Kohyama
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

9.  Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides.

Authors:  C Arturo Solares; Andrea E Edling; Justin M Johnson; Moo-Jin Baek; Keiko Hirose; Gordon B Hughes; Vincent K Tuohy
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Review of Animal Models of Neuromyelitis Optica.

Authors:  Melina V Jones; Nicolas Collongues; Jerome de Seze; Makoto Kinoshita; Yuji Nakatsuji; Michael Levy
Journal:  Mult Scler Relat Disord       Date:  2012-10       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.